If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 72.50
Bid: 60.00
Ask: 85.00
Change: -3.50 (-4.61%)
Spread: 25.00 (41.667%)
Open: 72.50
High: 72.50
Low: 72.50
Prev. Close: 76.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity, Director/PDMR Shareholding & TVR

31 May 2023 07:00

RNS Number : 0819B
Biome Technologies PLC
31 May 2023
 

31 May 2023

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Exercise of options, transaction in own shares, issue of equity and director/PDMR shareholdings

 

Total voting rights

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, announces the following transactions involving the Company's ordinary shares of 5p each ("Ordinary Shares").

 

Biome has received an exercise notice from its Chief Executive Officer, Paul Mines, in respect of share options over 26,666 Ordinary Shares granted on 30 January 2020 in lieu of a bonus accrued in 2018 and exercisable at 5p per share. The Company satisfied this exercise of share options on 30 May 2023, by transferring 16,710 Ordinary Shares out of treasury and via the allotment of 9,956 new Ordinary Shares. An application to the London Stock Exchange for the admission of 9,956 new Ordinary Shares to trading on AIM ("Admission") has been made and Admission is expected to occur on 5 June 2023.

 

Additionally, the Company was notified on 30 May 2023 that Paul Mines sold 13,333 Ordinary Shares on 30 May 2023 at a price of 111 pence per Ordinary Share in order to cover his tax and National Insurance liabilities arising from the exercise of share options referred to above. Following this sale and the receipt of Ordinary Shares from his option exercise, Paul Mines will have a total beneficial holding of 57,358 Ordinary Shares, which is equivalent to 1.52% of the voting rights in the enlarged issued share capital of the Company.

 

The Company was also notified on 30 May 2023 that Robert Smith, Biome's Chief Financial Officer, purchased 13,333 Ordinary Shares on 30 May 2023 into his personal ISA at a price of 119 pence per Ordinary Share. Following this purchase, Robert Smith will have a total beneficial holding of 18,901 Ordinary Shares, which is equivalent to 0.50% of the voting rights in the enlarged issued share capital of the Company.

 

Following these transactions, there are no Ordinary Shares held in treasury by the Company. Upon Admission, the total number of Ordinary Shares in issue will be 3,782,596. Therefore, upon Admission, the total number of voting rights in the Company will be 3,782,596, which may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules sourcebook.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Mines

2

Reason for the notification

a)

Position/status

Director - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Biome Technologies plc

b)

LEI

213800B9QI14B12TAO51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p in Biome Technologies plc. Identification code (ISIN) for Biome Technologies plc Ordinary Shares: GB00B9Z1M820

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price: 111 pence

 

Volume: 13,333

 

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

30 May 2023

f)

Place of the transaction

London Stock Exchange (XLON), AIM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Mines

2

Reason for the notification

a)

Position/status

Director - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Biome Technologies plc

b)

LEI

213800B9QI14B12TAO51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p in Biome Technologies plc. Identification code (ISIN) for Biome Technologies plc Ordinary Shares: GB00B9Z1M820

b)

Nature of the transaction

Exercise of share options

c)

Price(s) and volume(s)

Price: 5 pence

 

Volume: 26,666

 

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

30 May 2023

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Smith

2

Reason for the notification

a)

Position/status

Director - Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Biome Technologies plc

b)

LEI

213800B9QI14B12TAO51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5p in Biome Technologies plc. Identification code (ISIN) for Biome Technologies plc Ordinary Shares: GB00B9Z1M820

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price: 119 pence

 

Volume: 13,333

 

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

30 May 2023

f)

Place of the transaction

London Stock Exchange (XLON), AIM

 

 

Schedule of detailed information regarding disposals of Ordinary Shares made by the Company.

Schedule of Disposals

Shares disposed of:

Biome Technologies plc (ISIN: GB00B9Z1M820)

Date of disposals:

30 May 2023

Investment firm:

N/A

 

Aggregate information:

Venue

Volume-weightedaverage price, pence

Aggregated volume

Outside a trading venue

5p

16,710

 

Individual transactions:

Number of Ordinary Shares disposed of

Transaction price(pence per Ordinary Share)

Time of transaction

Trading venue

16,710

5p

30 May 2023

Outside a trading venue

 

 

-Ends-

 

For further information please contact:

Biome Technologies plc

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

 

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

 

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGZGFKNGFGFZM
Date   Source Headline
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.